Certain Anterior and Posterior Ocular Structure Measurements Acquired by Swept-Source Optical Coherence Tomography in Patients with Inflammatory Bowel Disease

Main Article Content

Arif Ülkü Yener
Muhammet Yener Akpınar
Evrim Karamanoğlu
Ferdane Pirinçci Sapmaz
Metin Uzman
Yaşar Nazlıgül


Objective: To measure some ocular parameters in inflammatory bowel disease and evaluate whether there are any differences between the measurements obtained from the patients and healthy subjects.
Methods: Thirteen patients with inflammatory bowel disease referred from the gastroenteroloji clinic and 14 control subjects selected from the individuals with minor complaints who admitted the ophthalmology outpatient clinic were included in the study. Average and segmental retinal nerve fiber layer thickness in four quadrant, average and sectoral ganglion cell inner plexiform layer thickness in in six guadrant, foveal and parafoveal vessel density in four quadrant, optic nerve head parameters, including rim area, disc area, horizontal cup-to-disc ratio, vertical cup-to-disc ratio, cup volume and additionally superficial/deep foveal avascular zone areas, choroid thickness, and central corneal thickness of the patients and controls were quantified using the swept-source optical coherence tomography.
Results: All measurements taken from the patients with inflammatory bowel disease and controls showed a great similarity and did not differ statistically.
Conclusion: Even though several inflammatory systemic diseases affect the eye and alter the particular structures, this study revealed that inflammatory bowel disease has no inluence on neural and vascular layers of the eye.

Article Details

Original Research


Ye Y, Pang Z, Chen W, Zu S, Zhou C. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015;8:22529-42.

Silva FA, Rodrigues BL, Avrizono ML, Leal RF. The immunological basis of inflammatory bowel disease. Gastroenterol Res Pract. 2016;2016:2097274.

Yamamoto-Furusho JK, Bosques-Padilla F, de-Paula J, Galiano MT, Ibanez P, Juliano F, et al. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn’s and Colitis Organisation. Rev Gastroenterol Mex. 2017;82:46-84.

Uniken Venema VT, Voskuil MD, Dijkstra G, Weersma RK, Festen FA. The genetic background of inflammatory bowel disease: from correlation to causality. J Pathol. 2017;241:146-58.

Peyrin-Biroulet L, Van Assche G, Gomez-Ulloa D, Garcia-Alvarez L, Lara N, Black CM, Kachroo S. Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2017;15:25-36.

Karlinger Y, Györke T, Makö E, Mester A, Tarjan Z. The epidemiology and pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000;35:154-67.

Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population based study. Am J Gastroenterol. 2001;96:1116-22.

Lin P, Tessler HH, Goldstein DA. Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation. Am J Ophthalmol. 2006;141:1097-104.

Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA. Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol. 2012;154:72-7.

Mendoza JL, Lana R, Taxonera C, Alba C, Izquierdo S, Diaz-Rubio M. Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis. Med Clin (Barc). 2005;125:297-300.

Levine JS, Burakoff R. Extraintestinal manifestations in inflammatory bowel disease. Gastroenterol Hepatol. 2011;7:235-41.

Troncoso LL, Biancardi AL, de Moraes HV, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: A review. World J Gastroenterol. 2017;28:5836-48.

Lee HJ, Song HJ, Jeong JH, Kim HU, Boo SJ, Na SY. Ophthalmologic manifestations in patients with inflammatory bowel disease. Intest Res. 2017;15:380-7.

Taylor SR, McCluskey P, Lightman S. The ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol. 2006,17:538-44.

Yılmaz S, Aydemir E, Maden A, Ünsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis. 2007;22:1027-30.

Thomas AS, Lin P. Ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol. 2016;27:552-60.

Crohn BB. Ocular lesions complicating ulcerative colitis. Am J Med Sci. 1925:169:260-7.

Granchi FD, Rembacken BJ. Inflammatory bowel disease and the eye. Surv Ophthalmol. 2003,48:663-76.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis. 2004;10:207-14.

Roberts H, Rai SN, Pan J, Rao JM, Keskey RC, Kanaan Z, et al. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion. 2014;90:122-9.

Curry DB, Moss AC. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1393-6.

Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. Scientific World Journal. 2015;2015:438402.

Mintz R, Feller ER, Bahr RL, Shah SA. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:135-9.

Paroli MP, Spinucci G, Bruscolini A, La Cava M, Abicca I. Uveitis preceding Crohn’s disease by 8 years. Int Ophthalmol. 2011;31:413-5.

Hwang IP, Jordan DR, Acharya V. Lacrimal gland inflammation as the presenting sign of Crohn’s disease. Can J Ophthalmol. 2001;36:212-3.

Garrity JA, Coleman AW, Matteson EL, Eggenberger ER, Waitzman DM. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138:925-30.

Zullow S, Fazelat A, Farrave FA. Central serous chorioretinopathy in a patient with ulcerative colitis with pouchitis on budesonide-EC. Inflamm Bowel Dis. 2017;23:E19.

Casalino G, Querques G, Corvi F, Borrelli E, Triolo G, Ramirez GA, Bandello F. Choroidal neovascularization in a patient with Crohn’s disease. Case Rep Ophthalmol. 2014;5:249-54.

Larsson J, Hansson-Lundblad C. Central retinal vein occlusion in two patients with inflammatory bowel disease. Retina. 2000;20:681-2.

Falavarjani KG, Parvaresh MM, Shahraki K, Nekoozadeh S, Amirfarhangi A. Central retinal artey occlusion in Crohn’s disease. JAAPOS. 2012;16:392-3.

McClelland C, Zaveri M, Walsh R, Fleisher J, Galetta S. Optic perineuritis as the presenting feature of Crohn’s disease. J Neuroophthalmol. 2012;32:345-7.

Önal IK, Yüksel E, Bayrakçeken K, Demir MM, Karaca EE, İbiş M, et al. Measurement and clinical implications of choroidal thickness in patients with inflammatory bowel disease. Arq Bras Ophthalmol. 2015;78:278-82.